| dc.date.accessioned | 2015-11-17T19:10:27Z | |
| dc.date.available | 2015-11-17T19:10:27Z | |
| dc.date.issued | 1997 | |
| dc.identifier.uri | http://hdl.handle.net/10852/47784 | |
| dc.language.iso | en | en_US |
| dc.publisher | Matematisk Institutt, Universitetet i Oslo | |
| dc.relation.ispartof | Preprint series. Statistical Research Report http://urn.nb.no/URN:NBN:no-23420 | |
| dc.relation.uri | http://urn.nb.no/URN:NBN:no-23420 | |
| dc.rights | © The Author(s) (1997). This material is protected by copyright law. Without explicit authorisation, reproduction is only allowed in so far as it is permitted by law or by agreement with a collecting society. | |
| dc.title | Assessment of the scientific documentation of the drugs etidronat (Didronate) and alendronat (Fosamax) for the reduction of the number of fractures among women with osteoporosis. An analysis based on Bayesian statistics. | en_US |
| dc.type | Research report | en_US |
| dc.rights.holder | Copyright 1997 The Author(s) | |
| dc.creator.author | Storvik, Geir | |
| dc.creator.author | Natvig, Bent | |
| dc.creator.author | Gåsemyr, Jørund | |
| dc.creator.author | Aursnes, Ivar | |
| dc.identifier.urn | URN:NBN:no-51799 | |
| dc.type.document | Forskningsrapport | en_US |
| dc.identifier.fulltext | Fulltext https://www.duo.uio.no/bitstream/handle/10852/47784/1/1997-9.pdf | |